UnitedHealth Group Incorporated $UNH is Vulcan Value Partners LLC’s 3rd Largest Position

Vulcan Value Partners LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 2.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,198,338 shares of the healthcare conglomerate’s stock after selling 24,487 shares during the quarter. UnitedHealth Group comprises about 7.5% of Vulcan Value Partners LLC’s holdings, making the stock its 3rd biggest holding. Vulcan Value Partners LLC owned 0.13% of UnitedHealth Group worth $413,876,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in UNH. LFA Lugano Financial Advisors SA purchased a new stake in UnitedHealth Group in the second quarter valued at approximately $25,000. Sagard Holdings Management Inc. purchased a new position in UnitedHealth Group during the 2nd quarter worth $29,000. Islay Capital Management LLC purchased a new position in shares of UnitedHealth Group during the second quarter worth about $31,000. Cloud Capital Management LLC purchased a new stake in UnitedHealth Group during the 3rd quarter valued at approximately $32,000. Finally, Grey Fox Wealth Advisors LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter valued at approximately $33,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Royal Bank Of Canada lowered their price objective on shares of UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating on the stock in a research report on Wednesday, January 28th. Deutsche Bank Aktiengesellschaft lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price objective on the stock. in a report on Wednesday, October 29th. Wells Fargo & Company reduced their price target on UnitedHealth Group from $400.00 to $370.00 and set an “overweight” rating for the company in a report on Friday, January 30th. Mizuho cut their price objective on UnitedHealth Group from $430.00 to $350.00 and set an “outperform” rating for the company in a research report on Thursday, February 5th. Finally, Sanford C. Bernstein reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. One analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $372.13.

Get Our Latest Stock Analysis on UNH

UnitedHealth Group Trading Up 0.1%

Shares of UNH opened at $290.11 on Monday. The firm has a 50 day simple moving average of $316.85 and a 200-day simple moving average of $325.30. The stock has a market cap of $262.79 billion, a price-to-earnings ratio of 21.99, a price-to-earnings-growth ratio of 1.33 and a beta of 0.41. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.82. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $606.36.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, topping analysts’ consensus estimates of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The company had revenue of $113.22 billion during the quarter, compared to analysts’ expectations of $113.38 billion. During the same period in the previous year, the firm posted $6.81 earnings per share. The business’s revenue for the quarter was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Recommended Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.